The Trade Behind Allergan’s Pullback, Cramer

[cnbc 3000083824]

Cramer’s analysis on Allergan shows that it’s a high-quality stock that can be bought into weakness.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.